These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 1144332)

  • 1. [Treatment of polycythemia with myelosan under ambulatory conditions].
    Krasiukova LI
    Probl Gematol Pereliv Krovi; 1975 May; 20(5):37-40. PubMed ID: 1144332
    [No Abstract]   [Full Text] [Related]  

  • 2. [Current aspects of the treatment of polycythemia vera under polyclinical conditions].
    Osechenskaia GV; Krasiukova LI
    Probl Gematol Pereliv Krovi; 1978 Jan; 23(1):21-4. PubMed ID: 628661
    [No Abstract]   [Full Text] [Related]  

  • 3. [The vascular manifestations of polycythemia].
    Viala JJ; Brun F; Chataing B
    Lyon Med; 1968 Jun; 219(23):1907-12 passim. PubMed ID: 5670634
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapeutic effect of busulfan in polycythemia].
    Popović K; Stanulovic D
    Med Pregl; 1971; 24(9):479-81. PubMed ID: 5156502
    [No Abstract]   [Full Text] [Related]  

  • 5. [The treatment of polycythemia vera with busulfan].
    Kratochvil J; Mrkos D
    Vnitr Lek; 1966 Jul; 12(7):673-81. PubMed ID: 5967585
    [No Abstract]   [Full Text] [Related]  

  • 6. Two cases of primary erythremia treated with Busulfan.
    Zawada W
    Mater Med Pol; 1974; 6(2):140-2. PubMed ID: 4431247
    [No Abstract]   [Full Text] [Related]  

  • 7. Procarbazine (Natulan) and busulfan in the treatment of polycythemia vera.
    Penttilä O; Ikkala E
    Ann Med Intern Fenn; 1968; 57(2):99-101. PubMed ID: 5706392
    [No Abstract]   [Full Text] [Related]  

  • 8. [Results of long-term therapy of essential polycythemia using myleran. Definition of criteria for an adequate posology].
    Maurice PA; Alberto P
    Schweiz Med Wochenschr; 1967 Nov; 97(44):1477-8. PubMed ID: 5593694
    [No Abstract]   [Full Text] [Related]  

  • 9. [Myleran treatment in polycythemia vera].
    Yde H
    Nord Med; 1971 Aug; 85(32):968. PubMed ID: 5568439
    [No Abstract]   [Full Text] [Related]  

  • 10. [Polycythemia vera: therapeutic use of busulfan. Comparison with radioactive phosphorous].
    Jamra M; Verrastro T
    Rev Hosp Clin Fac Med Sao Paulo; 1967; 22():Suppl:241-66. PubMed ID: 5629089
    [No Abstract]   [Full Text] [Related]  

  • 11. [Case of myelosan-induced hematopoietic aplasia in erythremia].
    Demidova AV; Siver AP; Pogorzhel'skiĭ VI
    Ter Arkh; 1977; 49(2):133-4. PubMed ID: 860217
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapy of polycythemia vera with myleran].
    Krykowski E; Wislawska B; Polkowska-Kulesza E
    Przegl Lek; 1965; 21(7):481-3. PubMed ID: 5848465
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapy of polycythemia vera with busulfan (myleran). Report on results in 40 patients].
    Urasiński I; Mysik M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1970; 94(4):360-6. PubMed ID: 4101127
    [No Abstract]   [Full Text] [Related]  

  • 14. [Ambulatory treatment of patients with chronic myeloid leukemia].
    Lobanova NA
    Ter Arkh; 1981; 53(9):25-8. PubMed ID: 6946602
    [No Abstract]   [Full Text] [Related]  

  • 15. [Acute hemopericardium due to acute thrombocytopenia developing during Busulphan treatment of polycythemia vera].
    Dyk T; Piotrowski M; Kostecka W
    Pol Tyg Lek; 1973 Feb; 28(7):259-60. PubMed ID: 4691200
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical and pharmacologic effects of high dose single agent busulfan with autologous bone marrow support in the treatment of solid tumors.
    Peters WP; Henner WD; Grochow LB; Olsen G; Edwards S; Stanbuck H; Stuart A; Gockerman J; Moore J; Bast RC
    Cancer Res; 1987 Dec; 47(23):6402-6. PubMed ID: 2824032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythropoiesis and erythropoietin in busulphan treated mice.
    Barrio Rendo ME; Alvarez Prado de Tombol ; Scaro JL
    Acta Physiol Lat Am; 1973; 23(5):327-33. PubMed ID: 4784627
    [No Abstract]   [Full Text] [Related]  

  • 18. [Results of long-term treatment of polycythemia vera with busulfan (Myleran) or dibromomannitol (Myelobromol): analysis of 4 clinical cases observed and treated during more than 7 years].
    Alberto P; Maurice PA
    Praxis; 1969 Sep; 58(38):1211-6. PubMed ID: 4982355
    [No Abstract]   [Full Text] [Related]  

  • 19. [Vercyte in the therapy of polycythemia].
    Fábryová L; Hrubisko M
    Vnitr Lek; 1972 Nov; 18(11):1113-6. PubMed ID: 4634660
    [No Abstract]   [Full Text] [Related]  

  • 20. [Chronic myelogenous leukemia. Results of therapy with busulfan].
    Olesen J; Videbaek A
    Nord Med; 1969 Oct; 82(41):1284-90. PubMed ID: 5260856
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.